Cargando…
S222. CLINICAL UTILITY OF PHARMACOGENETIC TESTING IN SCHIZOPHRENIA TREATMENT
BACKGROUND: Antipsychotics (APs), antidepressants (ADs) and mood stabilizers are essential components in treatment of most psychiatric disorders and in particular in schizophrenia. Unfortunately, among the various compounds which have been developed, lengthy trials are often required before the opti...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888109/ http://dx.doi.org/10.1093/schbul/sby018.1009 |